Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Sees Revenues Climb, Earnings Double in Q1

NEW YORK, April 23 (GenomeWeb News) - Molecular Devices' revenues grew and its earnings doubled during the first quarter, the company said yesterday.

 

Revenues increased to $27.3 million, from $24.6 million during the year-ago period.

 

Research and development costs decreased to $4 million, from $4.7 million during the first quarter last year.

 

The company's net income soared to $1.4 million, or $.1 per share, from $0.7 million, or $.05 per share, for the same period last year.

 

As of March 31, Molecular Devices had $50.4 million in cash and cash equivalents, and no short-term investments.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.